Abstract:Recent advances in microfluidics-based point-of-care testing (POCT) technology such as paper, array, and beads have shown promising results for diagnosing various infectious diseases. The fast and timely detection of viral infection has proven to be a critical step for deciding the therapeutic outcome in the current COVID-19 pandemic, which in turn not only enhances the patient survival rate but also reduces the disease-associated comorbidities. In the present scenario, rapid, noninvasive detection of the virus using low cost and high throughput microfluidics-based POCT devices embraces the advantages over existing diagnostic technologies, for which a centralized lab facility, expensive instruments, sample pretreatment, and skilled personnel are required. Microfluidic-based multiplexed POCT devices can be a boon for clinical diagnosis in developing countries that lacks a centralized health care system and resources. The microfluidic devices can be used for disease diagnosis and exploited for the development and testing of drug efficacy for disease treatment in model systems. The havoc created by the second wave of COVID-19 led several countries' governments to the back front. The lack of diagnostic kits, medical devices, and human resources created a huge demand for a technology that can be remotely operated with single touch and data that can be analyzed on a phone. Recent advancements in information technology and the use of smartphones led to a paradigm shift in the development of diagnostic devices, which can be explored to deal with the current pandemic situation. This review sheds light on various approaches for the development of cost-effective microfluidics POCT devices. The successfully used microfluidic devices for COVID-19 detection under clinical settings along with their pros and cons have been discussed here. Further, the integration of microfluidic devices with smartphones and wireless network systems using the Internet-of-things will enable readers for manufacturing advanced POCT devices for remote disease management in low resource settings.

Virus Detection: From State‐of‐the‐Art Laboratories to Smartphone‐Based Point‐of‐Care Testing

When smartphone enters food safety: A review in on-site analysis for foodborne pathogens using smartphone-assisted biosensors

Smartphone-based platforms implementing microfluidic detection with image-based artificial intelligence

Point-of-care testing based on smartphone: The current state-of-the-art (2017-2018)

Advances in Smartphone-Based Point-of-Care Diagnostics

Recent advances in point-of-care testing of COVID-19

Smartphone technology facilitates point-of-care nucleic acid diagnosis: a beginner’s guide

Detection of SARS-CoV-2 Based on Artificial Intelligence-Assisted Smartphone: A Review

Recent Progress on Rapid Diagnosis of COVID-19 by Point-of-care Testing Platforms.

Point-of-care Testing of Infectious Diseases: Recent Advances

Point-of-care diagnostics for infectious diseases: From methods to devices

Advances in rapid point-of-care virus testing

Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution

Real-time Colorimetric Quantitative Molecular Detection of Infectious Diseases on Smartphone-based Diagnostic Platform

Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives

Automatic smartphone-based microfluidic biosensor system at the point of care

Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic Technology

Micro/nano biomedical devices for point-of-care diagnosis of infectious respiratory diseases

Automatic Smartphone-Based Microfluidic Biosensor System at the Point of Care.

On‐Chip Optical Detection of Viruses: A Review

Hands-free smartphone-based diagnostics for simultaneous detection of Zika, Chikungunya, and Dengue at point-of-care